Tuula Rintala, King’s College Hospital, London, UK, shares her highlights in quality management from EBMT 2022. Ms Rintala mentions a comprehensive session about the 8th edition of the FACT-JACIE Standards for hematopoietic cellular therapy, as well as a presentation looking at the immune effector cells standards in relation to transplant centers and inspectors. Ms Rintala also talks on the GoCART initiative and its impact on the accreditation process and on delivering chimeric antigen receptor T-cell (CAR-T) therapies. This interview took place at the 48th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) 2022, which was held virtually.